ClinicalTrials.gg
CompletedNCT05409820Updated Jul 23, 2024

Comparative Analysis of Hypobaric Versus Hyperbaric Bupivacaine for Spinal Anesthesia in Day-Case Anorectal Surgery

An observational study in Anorectal Diseases, Hemorrhoids and Anal Polyp, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-07-23.

Sponsored by Ankara City Hospital Bilkent · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
80
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Spinal anesthesia for anorectal surgery ( fistulotomy, fissure repair, pilonidal sinus excision,hemorrhoidectomy..) is a popular and widely used method characterized by rapid onset, delivery, easy mobilization and short hospital history. In order to minimize complications after spinal anesthesia, the use of lower-dose local anesthesia with the saddle block method has recently become widespread. Bupivacaine is often used for this method. Bupivacaine can be used hypobaric or hyperbaric in spinal anesthesia.

Early mobilization and early discharge are important and necessary in an anorectal disease group that has such a high incidence and does not require rapid surgery and postoperative follow-up and hospitalization.Outpatient surgery is a very suitable surgical procedure for anorectal surgeries.

In the light of all this information, the aim of this study is to evaluate and observe the hemodynamic data, bromage scores, mobilization and discharge of patients who underwent spinal anesthesia with two different techniques.

Read the detailed description

In this study, it is aimed to reduce long hospital stays and postoperative complications by comparing the postoperative mobilization, urination and discharge times of the patients after spinal anesthesia using 5mg hypobaric and 5 mg hyperbaric bupivacaine in patients who will undergo outpatient anorectal surgery.

After the approval of the ethics committee in the operating room of the Ankara City Hospital, 68 patients who will undergo day surgery due to anorectal disease will be included in the study. This study was planned as observational.

Both genders, American society of anesthesiology(ASA) score 1-2, 68 patients between the ages of 18-65 will be included in the study. The patients will be evaluated in 2 groups of 34 people.

Patients with routine preoperative preparation, ECG, Spo2( oxygen saturation) and non-invasive blood pressure monitoring in the operating room and throughout the study will be included. Written informed consent will be obtained from patients.

ECG, Spo2 and noninvasive blood pressure monitoring of the patients who are taken back to the hospitalization service for postoperative follow-up after the operation will continue. Patients will be followed up with:

half-hourly intervals, first analgesic requirement, urination, mobilization times.

If there are no complications, the patients will be discharged. The next day, patients will be called and questioned in terms of spinal anesthesia-related complications (headache, low back pain, urinary dysfunction...) and their anesthetic satisfaction will be noted.

A total of minimum 68 (n1=34, n2=34) patients with effect size d=0.80, α=0.05 were found to be sufficient for 90% power in the sample size calculation.

Parameters to look at:

Operation time Intraoperative and postoperative vital monitoring need for sedation Time of sensory block to reach s4 dermatome The highest dermatome reached by sensory block Loss time of sensory block Modified bromage scale (5 minutes after spinal cord, end of operation, 1 postoperative 15 minutes, time to zero value) Time to first postoperative analgesic requirement Postoperative urination time Postoperative mobilization time Presence of complications related to spinal anesthesia patient satisfaction.

02

Conditions studied

  • Anorectal Diseases
  • Hemorrhoids
  • Anal Polyp
  • Pilonidal Sinus
  • Anal Fissures

Keywords

  • Day-case Surgery
  • Spinal Anesthesia
  • Anorectal Surgery
03

In context

Rectal Diseases

87 studies on the registry are indexed under Rectal Diseases; 14 are open to participants now.

This study's enrollment of 80 is below the median of 223 across 26 observational studies indexed under Rectal Diseases.

Browse Rectal Diseases studies →

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 443 studies on the registry; 111 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Both sexes undergoing anorectal surgery, 18-65 years old, ASA score 1-2 patients

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Both sexes undergoing anorectal surgery, 18-65 years old, 1-2 patients

Exclusion criteria

Exclusion Criteria:

  • be under the age of 18
  • be over 65
  • of 3 and greater than 3
  • patients with fever
  • those who are pregnant
  • Patients with kidney failure
  • Patients with hepatic insufficiency
  • Patients with heart failure
  • Patients with upper respiratory tract symptoms
  • Patients with coagulation disorders
  • Patients with infection in the lumbar region
  • Patients with \<18 and BMI >40
  • Patients with uncontrolled hypertension, diabetes, pheochromocytoma and thyroid dysfunction
  • Those who do not have the ability to read, write or understand the consent form
  • Patients who do not want to sign the consent form
  • Patients deemed unsuitable by the investigator
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
80 participants (actual)
Patient registry
No

Interventions

  • Procedureuse of different spinal anesthesia techniques

    Comparison of spinal anesthesia with 5 mg hypobaric bupivacaine and 5 mg hyperbaric bupivacaine in outpatients

06

What researchers measure

Primary outcomes

  1. Discharge Time

    to determine the time at which patients are ready for discharge

    Time frame: 1 day after surgery

Secondary outcomes

  1. Modified Bromage Scale

    to determine the amount of motor function

    Time frame: 5 minutes after spinal anesthesia End of the surgery (up to 1 hour) Postoperative 15 minutes Postoperative 30 minutes Postoperative 45 minutes Postoperative 60 minutes

  2. Time Of First Analgesic Need

    to measure when the pain started

    Time frame: 1 day after surgery

  3. Urination Time

    to determine the presence of urinary dysfunction

    Time frame: 1 day after surgery

  4. Mobilization Time

    with a modified bromage scale of zero and able to walk unaided

    Time frame: 1 day after surgery

  5. Postoperative Complication

    presence of headache, urinary dysfunction, postoperative nausea and vomiting

    Time frame: 1 day after surgery

  6. Blood Pressure

    systolic, diastolic and mean arterial pressure,to determine the hemodynamic effects of spinal anesthesia

    Time frame: it is registered in entry, intraop 5.minutes,10.minutes,15.minutes, 20.minutes, 25.minutes, 30.minutes, 35.minutes, 40.minutes, 45.minutes, 50.minutes, 55.minutes,60. minutes ,postoperative 1st hour ,postoperative 2nd hour,postoperative 3rd hour

  7. Heart Rate

    to determine the hemodynamic effects of spinal anesthesia

    Time frame: it is registered in entry, intraop 5.minutes,10.minutes,15.minutes, 20.minutes, 25.minutes, 30.minutes, 35.minutes, 40.minutes, 45.minutes, 50.minutes, 55.minutes,60. minutes ,postoperative 1st hour ,postoperative 2nd hour,postoperative 3rd hour

  8. Spo2

    to determine the hemodynamic effects of spinal anesthesia

    Time frame: it is registered in entry, intraop 5.minutes,10.minutes,15.minutes, 20.minutes, 25.minutes, 30.minutes, 35.minutes, 40.minutes, 45.minutes, 50.minutes, 55.minutes,60. minutes ,postoperative 1st hour ,postoperative 2nd hour,postoperative 3rd hour

  9. Number of Participants with Sedation Need

    to determine whether sufficient sensory block has occurred

    Time frame: intraoperative, during surgery

  10. The Highest Dermatome Reached By The Sensory Block

    to determine whether sufficient sensory block has occurred

    Time frame: intraoperative

  11. S4 Dermatome Sensory Blockage Time

    to determine the time it takes for adequate sensory block to occur for surgery

    Time frame: preoperative, intraoperative

  12. Time to Disappearance of Sensory Block

    to calculate the duration of the effect of spinal anesthesia

    Time frame: 1 day after surgery

07

Study locations

1 site
  • Ankara City Hospital
    Ankara, 06800, Turkey
08

References and documents

Publications

  • Honca M, Dereli N, Kose EA, Honca T, Kutuk S, Unal SS, Horasanli E. Low-dose levobupivacaine plus fentanyl combination for spinal anesthesia in anorectal surgery. Braz J Anesthesiol. 2015 Nov-Dec;65(6):461-5. doi: 10.1016/j.bjane.2014.01.007. Epub 2014 Feb 20. PubMed 26614142 ↗
  • Taspinar V, Sahin A, Donmez NF, Pala Y, Selcuk A, Ozcan M, Dikmen B. Low-dose ropivacaine or levobupivacaine walking spinal anesthesia in ambulatory inguinal herniorrhaphy. J Anesth. 2011 Apr;25(2):219-24. doi: 10.1007/s00540-010-1089-9. Epub 2011 Jan 12. PubMed 21225292 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2022 to primary completion in Jul 2022, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 17, 2022
First posted
Jun 8, 2022
StartActual
Feb 1, 2022
Primary completionActual
Jul 1, 2022
CompletionActual
Aug 1, 2022
Last update
Jul 23, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05409820
Responsible party
semih başkan (principle investigator, Ankara City Hospital Bilkent) — Principal investigator
First posted
Jun 8, 2022
Start date
Feb 1, 2022
Primary completion
Jul 1, 2022
Completion
Aug 1, 2022
Last update
Jul 23, 2024

Study contacts

Semih Başkan
study director · Ankara City Hospital Bilkent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion